Skip to main content
Log in

The Recovery of Beta-Cell Function is Critical for Antidiabetic Outcomes of Gastric Bypass in Asian Subjects with Type 2 Diabetes and a Body Mass Index Below 30

  • Brief Communication
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Type 2 diabetes (T2D) in Asian populations is characterized by a lower body mass index (BMI) than in Caucasian cases. This pilot study investigated antidiabetic outcomes after a Roux-en-Y gastric bypass (RYGB) in Asian subjects with T2D and BMI < 30. Fifteen Koreans with poorly controlled T2D and BMI 23–30 underwent RYGB. Two years after RYGB, seven patients achieved HbA1c < 6.5% without medication (target-achieved). The other cases also showed improved glycemic control. The insulin secretory response during an oral glucose tolerance test was significantly restored in the target-achieved group. Postoperative changes in insulin sensitivity and body weight did not differ between these groups. Beta-cell function improvement is an important determinant of the long-term antidiabetic outcomes of RYGB in Asian subjects with BMI < 30.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50. discussion 50-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–40.

    Article  CAS  PubMed  Google Scholar 

  3. WHO/IASO/IOTF The Asia-Pacific Perspective: Redefining Obesity and Its Treatment.: Sydney, 2000.

  4. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143–8.

    Article  PubMed  Google Scholar 

  5. Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35:1420–8.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wang GF, Yan YX, Xu N, et al. Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg. 2015;25:199–208.

    Article  PubMed  Google Scholar 

  7. Bojsen-Moller KN, Dirksen C, Jorgensen NB, et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes. 2014;63:1725–37.

    Article  PubMed  Google Scholar 

  8. Goldfine AB, Patti ME. Diabetes improvement following Roux-en-Y gastric bypass: understanding dynamic changes in insulin secretion and action. Diabetes. 2014;63:1454–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kasama K, Mui W, Lee WJ, et al. IFSO-APC consensus statements 2011. Obes Surg. 2012;22:677–84.

    Article  PubMed  Google Scholar 

  10. KDA. Diabetes fact sheet in Korea 2013. Seoul: Korea Diabetes Association, Korea Centers for Disease Control and Prevention. 2012.

Download references

Acknowledgements

The authors thank Boston BioEdit Inc., for assistance with the preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Min-Seon Kim or Yoonseok Heo.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Funding

This work was supported by grants from the Korean Health Technology R&D Project (H15C1322), Ministry of Health & Welfare, Republic of Korea (for Y.H.), and the National Research Foundation of Korea (2013M3C7A1056024, 2015M3A9E7029172 for M.-S.K.).

Ethical Approval

The study conforms to the Declaration of Helsinki II and was approved by the Institutional Review Board of Inha University Hospital and registered with the international clinical trial registry (#NCT01735253).

Informed Consent

All of the included subjects agreed to participate in our analysis and signed informed consent.

Additional information

Obin Kwon and Yeon Ji Lee were both authors who equally contributed to this study.

Electronic Supplementary Material

ESM 1

(DOCX 16 kb)

Supplementary Figure 1

Comparison of indices of (a) insulin resistance, (b) insulin sensitivity, (c) early-phase insulin secretion, and (d) compensatory insulin secretion for insulin resistance, according to the HbA1c level 2 years after Roux-en-Y gastric bypass surgery (RYGB). *P < 0.05 compared with the target-not-achieved group. Comparisons of group differences at a given time point were performed using the Wilcoxon signed-rank test. (JPEG 200 kb)

High Resolution Image (EPS 1108 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kwon, O., Lee, Y.J., Yu, J.H. et al. The Recovery of Beta-Cell Function is Critical for Antidiabetic Outcomes of Gastric Bypass in Asian Subjects with Type 2 Diabetes and a Body Mass Index Below 30. OBES SURG 27, 541–544 (2017). https://doi.org/10.1007/s11695-016-2455-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-016-2455-y

Keywords

Navigation